FDA approves immunotherapy for rectal cancer patients
The FDA granted accelerated approval for Jemperli to help certain rectal cancer patients avoid standard chemotherapy and surgery.
The FDA granted accelerated approval for Jemperli to help certain rectal cancer patients avoid standard chemotherapy and surgery.